{"status": "ok", "totalResults": 7, "articles": [{"source": {"id": null, "name": "Techstory.in"}, "author": null, "title": "Interest to purchase SpaceX flights increasing since Inspiration4 crew spaceflight - Techstory", "description": "As the crew Inspiration4 kept getting attention for the whole week, more civilians are curious to know about the upcoming civilian flights of SpaceX.", "url": "https://techstory.in/spacex-flights-increasing-since-inspiration4-crew-spaceflight/", "urlToImage": "https://techstory.in/wp-content/uploads/2021/09/Crew-Dragon-DM-1-orbit-tall-pano-SpaceX-crop-3.jpg", "publishedAt": "2021-09-24T06:41:52Z", "content": "SpaceX launched its first civilian crew spaceflight last week. As the crew Inspiration4 kept getting attention for the whole week, more civilians are curious to know about the upcoming civilian fligh\u2026 [+2286 chars]"}, {"source": {"id": null, "name": "The Edge Markets MY"}, "author": null, "title": "Sinovac's Covid-19 shot highly effective against serious illness \u2014 Malaysia study - The Edge Markets MY", "description": "KUALA LUMPUR (Sept 24): Sinovac's Covid-19 vaccine is highly effective against serious illness, although rival shots from Pfizer/BioNTech and AstraZeneca showed better protection rates, a large real world study from Malaysia showed.The latest data is a boost \u2026", "url": "https://www.theedgemarkets.com/article/sinovacs-covid19-shot-highly-effective-against-serious-illness-%E2%80%94-malaysia-study", "urlToImage": "https://assets.theedgemarkets.com/SAM-9046_0.jpg?CIjJ3rw4qt4YONTZmy_3306LgxPo08T8", "publishedAt": "2021-09-24T06:41:43Z", "content": "KUALA LUMPUR (Sept 24): Sinovac's Covid-19 vaccine is highly effective against serious illness, although rival shots from Pfizer/BioNTech and AstraZeneca showed better protection rates, a large real \u2026 [+2476 chars]"}, {"source": {"id": null, "name": "The Star Online"}, "author": "Zhuang Pinghui", "title": "Chinese biotech firm Clover says its vaccine is effective against multiple coronavirus variants - The Star Online", "description": "Trials show 79 per cent efficacy against any severity of illness from Delta, says company as it awaits WHO emergency use approvalClover will supply up to 414 million doses for global use on behalf of the Covax Facility, which provides vaccine access for low- \u2026", "url": "https://www.thestar.com.my/aseanplus/aseanplus-news/2021/09/24/chinese-biotech-firm-clover-says-its-vaccine-is-effective-against-multiple-coronavirus-variants", "urlToImage": "https://apicms.thestar.com.my/uploads/images/2021/09/24/1305994.jpg", "publishedAt": "2021-09-24T02:51:00Z", "content": "Clover Biopharmaceuticals, a Chinese biotech start-up that has developed a protein-based Covid-19 vaccine and is a supplier of Covax, said on Wednesday that trials showed the vaccine was 79 per cent \u2026 [+4760 chars]"}, {"source": {"id": null, "name": "CNA"}, "author": null, "title": "US CDC advisers back COVID-19 booster shots for those 65 and older, not for high-risk workers - CNA", "description": "WASHINGTON: A US\u00a0Centers for Disease Control and Prevention (CDC) advisory panel on Thursday (Sep 23) recommended a booster shot of the Pfizer and BioNTech COVID-19 vaccine for Americans aged 65 and older and some adults with underlying medical conditions tha\u2026", "url": "https://www.channelnewsasia.com/world/us-cdc-advisers-back-covid-19-booster-shots-those-65-and-older-not-high-risk-workers-2198296", "urlToImage": "https://onecms-res.cloudinary.com/image/upload/s--MbWYp9ub--/fl_relative%2Cg_south_east%2Cl_one-cms:core:watermark:reuters%2Cw_0.1/f_auto%2Cq_auto/c_fill%2Cg_auto%2Ch_676%2Cw_1200/v1/one-cms/core/2021-09-23t204645z_3_lynxmpeh8m0vo_rtroptp_3_health-coronavirus-usa-cdc.jpg?itok=fi7Qsjnc", "publishedAt": "2021-09-23T22:52:00Z", "content": "WASHINGTON: A US\u00a0Centers for Disease Control and Prevention (CDC) advisory panel on Thursday (Sep 23) recommended a booster shot of the Pfizer and BioNTech COVID-19 vaccine for Americans aged 65 and \u2026 [+2017 chars]"}, {"source": {"id": null, "name": "Kitco NEWS"}, "author": "http://www.facebook.com/kitconews", "title": "Gold sees sharp losses amid better risk appetite late this week - Kitco NEWS", "description": "Senior Technical Analyst Jim Wyckoff prepares investors with an overview of how the markets opened and closed. What moved metal prices? How do the technicals look? By looking at important developments", "url": "https://www.kitco.com/news/2021-09-23/Gold-sees-sharp-losses-amid-better-risk-appetite-late-this-week.html", "urlToImage": "https://www.kitco.com/news/2021-09-23/images/goldchart_0923_pm.png", "publishedAt": "2021-09-23T16:55:00Z", "content": "Editor's Note: With so much market volatility, stay on top of daily news! Get caught up in minutes with our speedy summary of today's must-read news and expert opinions. Sign up here! \r\n(Kitco News)\u00a0\u2026 [+3719 chars]"}, {"source": {"id": null, "name": "Wccftech"}, "author": "Hassan Mujtaba", "title": "TeamGroup Unveils Next-Gen T-Force DELTA RGB & Vulcan DDR5-5200 Memory, Cardea Liquid II AIO-Cooled & High-End NVMe PCIe Gen 4 SSDs - Wccftech", "description": "During its 2021 launch event, TeamGroup unleashed a range of brand new technologies including its next-gen DDR5 gaming memory and new PCIe/NVMe based SSD solutions. TeamGroup Showcases Its Next-Gen DDR5-5200 Gaming Memory Series, Also Intros Liquid-Cooled &am\u2026", "url": "https://wccftech.com/teamgroup-unveils-next-gen-t-force-delta-rgb-vulcan-ddr5-5200-memory-cardea-liquid-ii-aio-cooled-high-end-nvme-pcie-gen-4-ssds/", "urlToImage": "https://cdn.wccftech.com/wp-content/uploads/2021/09/TEAMGROUP-Online-Launch-Event-2021-Harnessing-the-Four-Elements-for-Ultimate-Cooling-Spotlighting-New-Products-with-Large-Capacities-and-the-Innovative-DDR5-Memory.jpg", "publishedAt": "2021-09-23T15:19:12Z", "content": "During its 2021 launch event, TeamGroup unleashed a range of brand new technologies including its next-gen DDR5 gaming memory and new PCIe/NVMe based SSD solutions.\r\n G.Skill Teases Its Next-Gen Trid\u2026 [+7072 chars]"}]}